MedtechNoterat

Magle Chemoswed

Bolaget ska äga och förvalta immateriella rättigheter, värdepapper, fast egendom, samt andra bolag inom läkemedelsområdet och idka därmed förenlig verksamhet.

Verksamhet enligt Bolagsverket
Org.nr
556913-4710
Registrerat
2012
Registrerad adress
Malmö
Börsnoterat
ja
På webbplatsen
Om bolaget · Produkter
Pressrum
Cision

Nyheter om Magle Chemoswed

Bolagets pressmeddelanden

De senaste meddelandena, som bolaget publicerat dem. Techindex skriver om det som är nyheter.

  1. MAGLE GROUP COMPLETES RESTRUCTURING OF ITS OUTSTANDING DEBT AND CAPITAL STRUCTURE MFN
  2. MAGLE GROUP COMPLETES SET-OFF ISSUE TO BONDHOLDERS AND THE DIRECTED SHARE ISSUES RESOLVED UPON BY THE EGM MFN
  3. Magle Chemoswed Holding AB (publ) appoints Aaron Wong as Chief Executive Officer MFN
  4. Magle Chemoswed Holding AB (publ) initiates implementation of restructuring following successful written procedure MFN
  5. Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB (publ) MFN
  6. Magle Group announces additional drawdown under bridge loan facility MFN
  7. Disciplinary Committee of Nasdaq Stockholm fines Magle Chemoswed Holding AB (publ) for breach of rulebook MFN
  8. Magle Chemoswed Holding Reports Financial Results For Second Quarter 2026 MFN
  9. MAGLE CHEMOSWED HOLDING AB (PUBL) ADVANCES PUBLICATION OF THE INTERIM REPORT FOR Q2 2026 MFN
  10. Magle Chemoswed Holding AB (publ) announces successful completion of the written procedure in relation to its senior secured bonds 2025/2028 and its senior secured bonds 2026/2028 MFN

Är du från bolaget? Skicka era pressmeddelanden till press@techindex.se eller via formuläret.

Fler bolag inom medtech

Alla bolag inom medtech →